John Gallagher
About John Gallagher
John E. Gallagher III (age 52) is Certara’s Senior Vice President and Chief Financial Officer, a role he has held since April 2023; prior roles include CFO of Cue Health and senior finance leadership positions at Becton Dickinson, NBCUniversal, GE and Ford . Under his tenure, 2024 revenue reached $385.1 million (+9% YoY) and Adjusted EBITDA was $122.0 million; the company emphasizes EBITDA margin in its pay programs and guided to low-30s adjusted EBITDA margin in 2025 commentary . Since 12/31/2020, Certara’s TSR translated an initial $100 investment to $27.97 by year-end 2024, and the company introduced a $100 million repurchase authorization (with $25 million executed in Q2 2025), while prioritizing R&D and new software launches including AI-enabled Certara IQ and cloud Phoenix .
Past Roles
| Organization | Role | Years | Strategic impact |
|---|---|---|---|
| Cue Health (NASDAQ: HLTH) | Chief Financial Officer | Mar 2021 – Mar 2023 | Public-company CFO; led finance through post-COVID transition . |
| Becton, Dickinson & Co. (BD) | SVP, CFO Medical Segment and Treasurer | Jul 2018 – Feb 2021 | Segment CFO; enterprise treasury leadership . |
| BD | SVP, Controller & Chief Accounting Officer | Dec 2014 – Jul 2018 | Led corporate controllership and accounting . |
| BD | Corporate Treasurer | 2012 – 2018 | Responsible for corporate finance and FP&A . |
| NBCUniversal | VP, Financial Planning & Analysis | Oct 2009 – Sep 2012 | Led FP&A for diversified media portfolio . |
| General Electric | Assistant Controller, Corporate Treasury | Oct 2006 – Oct 2009 | Treasury accounting leadership . |
| Ford Motor Company | Various roles (Treasury, Internal Audit, Product Dev.) | Early career | Rotational finance and audit experience . |
Fixed Compensation
| Year | Base Salary ($) | Target Bonus (%) | Target Bonus ($) | Actual Bonus Paid ($) | Notes |
|---|---|---|---|---|---|
| 2024 | 592,249 | 50% | 296,125 | 219,132 (74% multiplier) | AIB metrics: 80% Adj. EBITDA, 20% revenue; blended corporate/business unit construct for CFO . |
| 2023 | 431,250 | 50% (unchanged vs 2023) | N/A | 184,000 (AIB) | Also received $435,750 in “Bonus ($)” (includes transition/other items); A&R agreement reimbursed $235,750 for unpaid bonus from prior employer with recoup if recovered . |
Performance Compensation
Annual Incentive (AIB Plan) – 2024 Design and Payout
- Metrics and weighting: Adjusted EBITDA (80%) and Revenue (20%), applied to corporate and divisional scorecards; CFO multiplier uses 20% company-wide + 80% blended division rate .
- Threshold: If company-wide adjusted EBITDA <90% of target, no payout (met in 2024) .
- 2024 Payout for Gallagher: 74% multiplier on $296,125 target = $219,132 .
| Metric | Weighting | Target | Actual | Payout/Multiplier | Vesting/Timing |
|---|---|---|---|---|---|
| Adjusted EBITDA | 80% | Not disclosed | >90% of target achieved (threshold crossed) | Included in 74% overall multiplier | Paid in cash in 2025 for FY2024 . |
| Revenue | 20% | Not disclosed | Achievement above threshold (by unit) | Included in 74% overall multiplier | Paid in cash in 2025 for FY2024 . |
Long-Term Incentives (LTI)
- Vehicle mix: 40% time-based RSUs; 60% PSUs (3-year performance) .
- 2024 grant (Apr 1, 2024): RSUs 45,571; Target PSUs 68,357; grant-date fair value $2,123,846 .
- PSU metrics and gates: Annual revenue (Tranche I) and adjusted EBITDA (Tranche II) over FY2024-2026; linear scale (50%-200%); forfeit if average EBITDA margin <20% over first two years; rTSR modifier ±20% vs peer group .
- 2023 outstanding: Target PSUs 56,848; RSUs 37,898 (3-year vest) and 29,326 (2-year) .
| Grant | Instrument | Quantity | Key Terms | Status |
|---|---|---|---|---|
| 2024 LTI (Apr 1, 2024) | RSUs | 45,571 | Vests 1/3 on Apr 1 of 2025, 2026, 2027 | 1/3 vested 4/1/2025 . |
| 2024 LTI (Apr 1, 2024) | PSUs (target) | 68,357 | 3-year performance (2024–2026); revenue and adj. EBITDA tranches; rTSR modifier; margin gate | Outstanding. |
| 2023 LTI (Apr 1, 2023) | RSUs | 29,326 | Two-year vesting; half vested 4/1/2024, completes 4/1/2025 | In-progress. |
| 2023 LTI (Apr 1, 2023) | RSUs | 37,898 | Vests 1/3 on Apr 1 of 2024, 2025, 2026 | In-progress. |
| 2023 LTI (Apr 1, 2023) | PSUs (target) | 56,848 | 3-year performance (2023–2025); earned/distributed after period | Outstanding. |
Equity Ownership & Alignment
| Item | Detail |
|---|---|
| Total beneficial ownership | 60,704 shares; <1% of outstanding as of Mar 28, 2025 . |
| Unvested RSUs (12/31/2024) | 85,500 units; market value $910,575 at $10.65/share . |
| Target PSUs outstanding (12/31/2024) | 125,205 units; market/payout value $1,333,433 at $10.65/share (performance/payout contingent) . |
| Next vesting dates/sizes | RSUs: 1/3 of 2024 grant vested 4/1/2025; remaining 2/3 vest 4/1/2026 and 4/1/2027; 2023 RSUs vest 4/1/2025 and 4/1/2026 per schedules . |
| Ownership guidelines | Executives must hold 2x base salary; assessed annually on Feb 1 . |
| Compliance status | As of Feb 1, 2025, all NEOs met minimum equity ownership thresholds (allowing for initial compliance period) . |
| Hedging/pledging | Hedging prohibited; pledging requires pre-clearance from General Counsel . |
| Options outstanding | None disclosed for executives; company is not currently granting options . |
Employment Terms
- Start date and role: Appointed SVP & CFO effective April 1, 2023 .
- Initial compensation on hire: Base salary $575,000; target bonus 50% of base; sign-on equity value $2.75 million (PSUs $1.26m; RSUs $0.84m vesting over 3 years; RSUs $0.65m vesting over 2 years) .
- Amended and Restated Employment Agreement (Nov 7, 2023): Company paid $235,750 for unpaid prior-employer bonus (reimbursable to Certara upon recovery) and agreed to reimburse legal fees related to that claim .
- Severance (no cause/good reason, no CIC): Six months’ base salary continuation; payment of full annual target bonus amount for current year; accrued obligations .
- Change-in-control (double-trigger): Six months’ base salary; full annual target bonus for current year; accelerated vesting value for unvested RSUs ($910,575 at 12/31/2024); estimated value for PSUs ($873,826; subject to performance determination) .
- Restrictive covenants: Perpetual confidentiality and non-disparagement; IP assignment; non-compete during employment and for one year thereafter; non-solicit of employees/customers during employment and for one year thereafter .
- Clawback: Company-adopted Dodd-Frank compliant clawback in 2023 covering incentive compensation tied to financial reporting measures .
Performance & Track Record
| Indicator | Detail |
|---|---|
| Revenue growth (FY2024) | $385.1 million, +9% YoY vs. $354.3 million in 2023 . |
| Adjusted EBITDA (FY2024) | $122.0 million (company-selected measure for pay-versus-performance) . |
| TSR context | $100 invested on 12/31/2020 worth $27.97 on 12/31/2024 (S&P Small Cap 600 Healthcare peer TSR $82.64 over same window) . |
| Strategy and capital allocation (CFO commentary) | Prioritizing R&D and new software (Certara IQ, cloud Phoenix, Pinnacle 21 Enterprise); $100m buyback authorization with $25m executed in Q2 2025; continued M&A screening with software tilt . |
Compensation Structure Analysis
- Mix and leverage: High share of at-risk pay via AIB and PSUs aligns realized pay with revenue/EBITDA and relative TSR; AIB weighted 80% to Adjusted EBITDA encourages profitability discipline; revenue receives 20% weighting .
- Metric calibration and rigor: 2024 AIB required ≥90% of Adjusted EBITDA target to fund; 2024 multiplier for CFO was 74%, below target, indicating formulaic restraint; no discretionary upward adjustments were made to AIB outcomes .
- Equity design: 3-year PSUs with EBITDA and revenue tranches, 20% EBITDA margin gate and rTSR modifier strengthen pay-for-performance; time-based RSUs provide retention continuity .
- Governance safeguards: No excise tax gross-ups; robust clawback; hedging prohibited; pledging requires pre-clearance; stock ownership guidelines enforced, with NEOs in compliance as of 2/1/2025 .
- Shareholder sentiment: 2024 Say-on-Pay passed with 94.8% approval, supporting the program design .
Risk Indicators & Insider Selling Pressure
- Scheduled vesting cadence: Significant RSU tranches vest around April 1 each year (e.g., 2024 and 2023 grants), potentially creating periodic selling windows and supply; 2024 RSUs vest 4/1/2025–2027; 2023 RSUs vest through 4/1/2026 .
- Pledging/hedging: Policy restricts pledging (pre-clearance) and prohibits hedging, reducing misalignment risks; no individual pledging by Gallagher disclosed .
- Change-in-control economics: Double-trigger treatment with cash severance equal to 6 months salary plus full-year target bonus and equity acceleration provides retention but limits windfalls relative to CEO terms; estimated RSU and PSU values detailed in proxy .
- No option repricing/red flags: Company noted it is not granting options currently and does not disclose option repricing; no tax gross-ups; presence of clawback .
Equity Detail and Vesting Schedules
| Award | Grant date | Quantity | Vesting schedule | Notes |
|---|---|---|---|---|
| RSUs | Apr 1, 2024 | 45,571 | 1/3 on 4/1/2025; 1/3 on 4/1/2026; 1/3 on 4/1/2027 | Time-based retention. |
| PSUs (target) | Apr 1, 2024 | 68,357 | 3-year performance (2024–2026); payout in early 2027 | Rev/Adj. EBITDA tranches; rTSR modifier; 20% margin gate . |
| RSUs | Apr 1, 2023 | 29,326 | 50% on 4/1/2024; 50% on 4/1/2025 | Two-year vest. |
| RSUs | Apr 1, 2023 | 37,898 | 1/3 on 4/1/2024; 1/3 on 4/1/2025; 1/3 on 4/1/2026 | Three-year vest. |
| PSUs (target) | Apr 1, 2023 | 56,848 | 3-year performance (2023–2025); payout after final determination | Outstanding. |
Employment Contracts, Severance, and Change of Control
| Term | Without Cause / Good Reason | Change in Control (Double-Trigger) |
|---|---|---|
| Cash severance | 6 months base salary | 6 months base salary . |
| Bonus treatment | Full annual target bonus for current year (pro rata deemed 100%) | Full annual target bonus for current year . |
| Equity treatment | See plan and award terms; no automatic RSU vesting absent CIC | RSUs accelerate (Gallagher est. $910,575 at 12/31/2024); PSUs per performance determination (Gallagher est. $873,826) . |
| Restrictive covenants | Confidentiality, non-disparagement, IP assignment, 1-year non-compete and non-solicit | Same as left. |
| Clawback | Dodd-Frank compliant, adopted 2023 | Applicable. |
Investment Implications
- Alignment and discipline: High at-risk mix, rigorous AIB guardrails (90% EBITDA threshold) and multi-year PSUs with rTSR and margin gate support pay-performance alignment and capital discipline .
- Retention vs. liquidity events: Meaningful RSU vests each April could create episodic supply; however, ownership guidelines and anti-hedging reduce misalignment; no pledging disclosed .
- Execution focus: CFO’s strategy emphasizes accelerating organic software growth via R&D and product launches (Certara IQ, cloud Phoenix), with balanced capital allocation (M&A screening, new $100m buyback; $25m executed), which can support LT growth and per-share metrics if sustained .
- Risk checks: No excise tax gross-ups, robust clawback, and no option repricing reduce governance risk; say-on-pay support (94.8% in 2024) indicates shareholder acceptance of program structure .